ICU Medical has recently come under pressure as analysts flagged muted 2.1% annual revenue growth, a projected 7.7% sales decline over the next year, and a contraction in free cash flow margins, ...

Earlier in December 2025, BofA Securities upgraded Schrödinger, Inc. after the company shifted away from internal drug development to concentrate on its core computational software business. This ...